SUVEN.NS · Suven Life Sciences Limited
India · RS rating 49 · As of 2026-10-14
| Price | 285.45 INR |
|---|---|
| 1-day change | +0.6% |
| RS rating (overall / 1M / 3M / 12M) | 49 / 3 / 13 / 85 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 39 / 44 / 22 |
| Industry group (rank) | Pharma - API & CRAMS (30) |
| EPS growth Q/Q | -139.6% |
| Sales growth Q/Q | +134.6% |
| Distance from 52-week high | +27.2% |
| Market cap (USD) | $839.8M |